APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valacyclovir Oral

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Valacyclovir Oral Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025199 pages

Choose your research edition.

Industry ResearchValacyclovir Oral Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Valacyclovir Oral Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Valacyclovir Oral Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valacyclovir Oral Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Valacyclovir Oral Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Valacyclovir Oral market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Valacyclovir Oral is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valacyclovir Oral is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valacyclovir Oral is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Valacyclovir Oral is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valacyclovir Oral include GSK, Teva, Sun Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Sandoz, Mylan, Lunan Pharmaceutical, Zydus Pharmaceuticals and Wockhardt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valacyclovir Oral market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valacyclovir Oral and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valacyclovir Oral sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valacyclovir Oral market size, projected growth trends, production technologies, key applications, and end-use industries.

Valacyclovir Oral Segment by Company

GSK

Teva

Sun Pharmaceutical

Shandong Luoxin Pharmaceutical Group

Sandoz

Mylan

Lunan Pharmaceutical

Zydus Pharmaceuticals

Wockhardt

West-Ward Pharmaceuticals

Time Cap Labs

Tasly

Jubilant Pharma

Cipla

Aurobindo Pharma

Apotex

Valacyclovir Oral Segment by Type

1000mg Tablet

300mg Tablet

500mg Tablet

Others

Valacyclovir Oral Segment by Application

Hospital

Drug Store

Valacyclovir Oral Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valacyclovir Oral market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valacyclovir Oral and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valacyclovir Oral.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valacyclovir Oral market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valacyclovir Oral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Valacyclovir Oral in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Valacyclovir Oral in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Valacyclovir Oral Industry Trends Table 2. Valacyclovir Oral Industry Drivers Table 3. Valacyclovir Oral Industry Opportunities and Challenges Table 4. Valacyclovir Oral Industry Restraints Table 5. Global Valacyclovir Oral Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Valacyclovir Oral Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Valacyclovir Oral Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Valacyclovir Oral Sales Market Share by Manufacturers Table 9. Global Valacyclovir Oral Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Valacyclovir Oral Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Valacyclovir Oral Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Valacyclovir Oral Manufacturers, Product Type & Application Table 13. Global Valacyclovir Oral Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Valacyclovir Oral by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1000mg Tablet Table 17. Major Manufacturers of 300mg Tablet Table 18. Major Manufacturers of 500mg Tablet Table 19. Major Manufacturers of Others Table 20. Global Valacyclovir Oral Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Valacyclovir Oral Sales by Type (2021-2026) & (W Units) Table 22. Global Valacyclovir Oral Sales by Type (2027-2032) & (W Units) Table 23. Global Valacyclovir Oral Sales Market Share by Type (2021-2026) Table 24. Global Valacyclovir Oral Sales Market Share by Type (2027-2032) Table 25. Global Valacyclovir Oral Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Valacyclovir Oral Revenue by Type (2021-2026) & (W Units) Table 27. Global Valacyclovir Oral Revenue by Type (2027-2032) & (W Units) Table 28. Global Valacyclovir Oral Revenue Market Share by Type (2021-2026) Table 29. Global Valacyclovir Oral Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Drug Store Table 32. Global Valacyclovir Oral Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Valacyclovir Oral Sales by Application (2021-2026) & (W Units) Table 34. Global Valacyclovir Oral Sales by Application (2027-2032) & (W Units) Table 35. Global Valacyclovir Oral Sales Market Share by Application (2021-2026) Table 36. Global Valacyclovir Oral Sales Market Share by Application (2027-2032) Table 37. Global Valacyclovir Oral Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Valacyclovir Oral Revenue by Application (2021-2026) & (W Units) Table 39. Global Valacyclovir Oral Revenue by Application (2027-2032) & (W Units) Table 40. Global Valacyclovir Oral Revenue Market Share by Application (2021-2026) Table 41. Global Valacyclovir Oral Revenue Market Share by Application (2027-2032) Table 42. Global Valacyclovir Oral Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Valacyclovir Oral Sales by Region (2021-2026) & (W Units) Table 44. Global Valacyclovir Oral Sales Market Share by Region (2021-2026) Table 45. Global Valacyclovir Oral Sales Forecasted by Region (2027-2032) & (W Units) Table 46. Global Valacyclovir Oral Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Valacyclovir Oral Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 48. North America Valacyclovir Oral Sales by Country (2021-2026) & (W Units) Table 49. North America Valacyclovir Oral Sales by Country (2027-2032) & (W Units) Table 50. Europe Valacyclovir Oral Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. Europe Valacyclovir Oral Sales by Country (2021-2026) & (W Units) Table 52. Europe Valacyclovir Oral Sales by Country (2027-2032) & (W Units) Table 53. Asia Pacific Valacyclovir Oral Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Asia Pacific Valacyclovir Oral Sales by Country (2021-2026) & (W Units) Table 55. Asia Pacific Valacyclovir Oral Sales by Country (2027-2032) & (W Units) Table 56. South America, Middle East and Africa Valacyclovir Oral Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. South America, Middle East and Africa Valacyclovir Oral Sales by Country (2021-2026) & (W Units) Table 58. South America, Middle East and Africa Valacyclovir Oral Sales by Country (2027-2032) & (W Units) Table 59. Global Valacyclovir Oral Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Valacyclovir Oral Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Valacyclovir Oral Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Valacyclovir Oral Revenue Market Share by Region (2021-2026) Table 63. Global Valacyclovir Oral Revenue Market Share by Region (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. GSK Valacyclovir Oral Product Portfolio Table 68. GSK Recent Development Table 69. Teva Company Information Table 70. Teva Business Overview Table 71. Teva Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Teva Valacyclovir Oral Product Portfolio Table 73. Teva Recent Development Table 74. Sun Pharmaceutical Company Information Table 75. Sun Pharmaceutical Business Overview Table 76. Sun Pharmaceutical Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sun Pharmaceutical Valacyclovir Oral Product Portfolio Table 78. Sun Pharmaceutical Recent Development Table 79. Shandong Luoxin Pharmaceutical Group Company Information Table 80. Shandong Luoxin Pharmaceutical Group Business Overview Table 81. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product Portfolio Table 83. Shandong Luoxin Pharmaceutical Group Recent Development Table 84. Sandoz Company Information Table 85. Sandoz Business Overview Table 86. Sandoz Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sandoz Valacyclovir Oral Product Portfolio Table 88. Sandoz Recent Development Table 89. Mylan Company Information Table 90. Mylan Business Overview Table 91. Mylan Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Mylan Valacyclovir Oral Product Portfolio Table 93. Mylan Recent Development Table 94. Lunan Pharmaceutical Company Information Table 95. Lunan Pharmaceutical Business Overview Table 96. Lunan Pharmaceutical Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Lunan Pharmaceutical Valacyclovir Oral Product Portfolio Table 98. Lunan Pharmaceutical Recent Development Table 99. Zydus Pharmaceuticals Company Information Table 100. Zydus Pharmaceuticals Business Overview Table 101. Zydus Pharmaceuticals Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Zydus Pharmaceuticals Valacyclovir Oral Product Portfolio Table 103. Zydus Pharmaceuticals Recent Development Table 104. Wockhardt Company Information Table 105. Wockhardt Business Overview Table 106. Wockhardt Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Wockhardt Valacyclovir Oral Product Portfolio Table 108. Wockhardt Recent Development Table 109. West-Ward Pharmaceuticals Company Information Table 110. West-Ward Pharmaceuticals Business Overview Table 111. West-Ward Pharmaceuticals Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. West-Ward Pharmaceuticals Valacyclovir Oral Product Portfolio Table 113. West-Ward Pharmaceuticals Recent Development Table 114. Time Cap Labs Company Information Table 115. Time Cap Labs Business Overview Table 116. Time Cap Labs Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Time Cap Labs Valacyclovir Oral Product Portfolio Table 118. Time Cap Labs Recent Development Table 119. Tasly Company Information Table 120. Tasly Business Overview Table 121. Tasly Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Tasly Valacyclovir Oral Product Portfolio Table 123. Tasly Recent Development Table 124. Jubilant Pharma Company Information Table 125. Jubilant Pharma Business Overview Table 126. Jubilant Pharma Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Jubilant Pharma Valacyclovir Oral Product Portfolio Table 128. Jubilant Pharma Recent Development Table 129. Cipla Company Information Table 130. Cipla Business Overview Table 131. Cipla Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Cipla Valacyclovir Oral Product Portfolio Table 133. Cipla Recent Development Table 134. Aurobindo Pharma Company Information Table 135. Aurobindo Pharma Business Overview Table 136. Aurobindo Pharma Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Aurobindo Pharma Valacyclovir Oral Product Portfolio Table 138. Aurobindo Pharma Recent Development Table 139. Apotex Company Information Table 140. Apotex Business Overview Table 141. Apotex Valacyclovir Oral Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Apotex Valacyclovir Oral Product Portfolio Table 143. Apotex Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Valacyclovir Oral Distributors List Table 147. Valacyclovir Oral Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Valacyclovir Oral Product Image Figure 2. Global Valacyclovir Oral Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valacyclovir Oral Market Size (2021-2032) & (US$ Million) Figure 4. Global Valacyclovir Oral Sales (2021-2032) & (W Units) Figure 5. Global Valacyclovir Oral Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Valacyclovir Oral Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1000mg Tablet Image Figure 9. 300mg Tablet Image Figure 10. 500mg Tablet Image Figure 11. Others Image Figure 12. Global Valacyclovir Oral Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Valacyclovir Oral Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Valacyclovir Oral Sales Market Share by Type (2021-2032) Figure 15. Global Valacyclovir Oral Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Valacyclovir Oral Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Valacyclovir Oral Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Drug Store Image Figure 20. Global Valacyclovir Oral Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Valacyclovir Oral Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Valacyclovir Oral Sales Market Share by Application (2021-2032) Figure 23. Global Valacyclovir Oral Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Valacyclovir Oral Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Valacyclovir Oral Revenue Market Share by Application (2021-2032) Figure 26. North America Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 27. North America Valacyclovir Oral Sales Market Share by Country (2021-2032) Figure 28. U.S. Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Canada Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Mexico Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Valacyclovir Oral Sales Market Share by Country (2021-2032) Figure 33. Germany Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 34. France Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 35. U.K. Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Italy Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Netherlands Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Valacyclovir Oral Sales Market Share by Country (2021-2032) Figure 40. China Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Japan Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 42. South Korea Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Southeast Asia Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 44. India Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Australia Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Valacyclovir Oral Sales Market Share by Country (2021-2032) Figure 48. Brazil Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South Africa Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Saudi Arabia Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Turkey Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Argentina Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 53. UAE Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Egypt Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Chile Valacyclovir Oral Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Global Valacyclovir Oral Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Valacyclovir Oral Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Valacyclovir Oral Revenue (2021-2032) & (US$ Million) Figure 59. North America Valacyclovir Oral Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Valacyclovir Oral Revenue (2021-2032) & (US$ Million) Figure 61. Europe Valacyclovir Oral Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Valacyclovir Oral Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Valacyclovir Oral Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Valacyclovir Oral Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Valacyclovir Oral Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Valacyclovir Oral Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Valacyclovir Oral Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1000mg Tablet
  • 300mg Tablet
  • 500mg Tablet
  • Others
Applications
  • Hospital
  • Drug Store
Companies covered
  • GSK
  • Teva
  • Sun Pharmaceutical
  • Shandong Luoxin Pharmaceutical Group
  • Sandoz
  • Mylan
  • Lunan Pharmaceutical
  • Zydus Pharmaceuticals
  • Wockhardt
  • West-Ward Pharmaceuticals
  • Time Cap Labs
  • Tasly
  • Jubilant Pharma
  • Cipla
  • Aurobindo Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Valacyclovir Oral Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Valacyclovir Oral Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Valacyclovir Oral Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Valacyclovir Oral Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Valacyclovir Oral Market Dynamics
  1. 2.1 Valacyclovir Oral Industry Trends
  2. 2.2 Valacyclovir Oral Industry Drivers
  3. 2.3 Valacyclovir Oral Industry Opportunities and Challenges
  4. 2.4 Valacyclovir Oral Industry Restraints
3 Valacyclovir Oral Market by Manufacturers
  1. 3.1 Global Valacyclovir Oral Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Valacyclovir Oral Sales by Manufacturers (2021-2026)
  3. 3.3 Global Valacyclovir Oral Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Valacyclovir Oral Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valacyclovir Oral Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Valacyclovir Oral Manufacturers, Product Type & Application
  7. 3.7 Global Valacyclovir Oral Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valacyclovir Oral Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valacyclovir Oral Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valacyclovir Oral Tier 1, Tier 2, and Tier 3
4 Valacyclovir Oral Market by Type
  1. 4.1 Valacyclovir Oral Type Introduction
  2. 4.1.1 1000mg Tablet
  3. 4.1.2 300mg Tablet
  4. 4.1.3 500mg Tablet
  5. 4.1.4 Others
  6. 4.2 Global Valacyclovir Oral Sales by Type
  7. 4.2.1 Global Valacyclovir Oral Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Valacyclovir Oral Sales by Type (2021-2032)
  9. 4.2.3 Global Valacyclovir Oral Sales Market Share by Type (2021-2032)
  10. 4.3 Global Valacyclovir Oral Revenue by Type
  11. 4.3.1 Global Valacyclovir Oral Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Valacyclovir Oral Revenue by Type (2021-2032)
  13. 4.3.3 Global Valacyclovir Oral Revenue Market Share by Type (2021-2032)
5 Valacyclovir Oral Market by Application
  1. 5.1 Valacyclovir Oral Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Valacyclovir Oral Sales by Application
  5. 5.2.1 Global Valacyclovir Oral Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Valacyclovir Oral Sales by Application (2021-2032)
  7. 5.2.3 Global Valacyclovir Oral Sales Market Share by Application (2021-2032)
  8. 5.3 Global Valacyclovir Oral Revenue by Application
  9. 5.3.1 Global Valacyclovir Oral Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Valacyclovir Oral Revenue by Application (2021-2032)
  11. 5.3.3 Global Valacyclovir Oral Revenue Market Share by Application (2021-2032)
6 Global Valacyclovir Oral Sales by Region
  1. 6.1 Global Valacyclovir Oral Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valacyclovir Oral Sales by Region (2021-2032)
  3. 6.2.1 Global Valacyclovir Oral Sales by Region (2021-2026)
  4. 6.2.2 Global Valacyclovir Oral Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Valacyclovir Oral Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Valacyclovir Oral Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Valacyclovir Oral Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Valacyclovir Oral Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Valacyclovir Oral Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Valacyclovir Oral Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Valacyclovir Oral Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Valacyclovir Oral Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Valacyclovir Oral Revenue by Region
  1. 7.1 Global Valacyclovir Oral Revenue by Region
  2. 7.1.1 Global Valacyclovir Oral Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Valacyclovir Oral Revenue by Region (2021-2026)
  4. 7.1.3 Global Valacyclovir Oral Revenue by Region (2027-2032)
  5. 7.1.4 Global Valacyclovir Oral Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Valacyclovir Oral Revenue (2021-2032)
  8. 7.2.2 North America Valacyclovir Oral Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Valacyclovir Oral Revenue (2021-2032)
  11. 7.3.2 Europe Valacyclovir Oral Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Valacyclovir Oral Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Valacyclovir Oral Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Valacyclovir Oral Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Valacyclovir Oral Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Valacyclovir Oral Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Valacyclovir Oral Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sun Pharmaceutical
  14. 8.3.1 Sun Pharmaceutical Company Information
  15. 8.3.2 Sun Pharmaceutical Business Overview
  16. 8.3.3 Sun Pharmaceutical Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Valacyclovir Oral Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Recent Developments
  19. 8.4 Shandong Luoxin Pharmaceutical Group
  20. 8.4.1 Shandong Luoxin Pharmaceutical Group Company Information
  21. 8.4.2 Shandong Luoxin Pharmaceutical Group Business Overview
  22. 8.4.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product Portfolio
  24. 8.4.5 Shandong Luoxin Pharmaceutical Group Recent Developments
  25. 8.5 Sandoz
  26. 8.5.1 Sandoz Company Information
  27. 8.5.2 Sandoz Business Overview
  28. 8.5.3 Sandoz Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sandoz Valacyclovir Oral Product Portfolio
  30. 8.5.5 Sandoz Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Valacyclovir Oral Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Lunan Pharmaceutical
  38. 8.7.1 Lunan Pharmaceutical Company Information
  39. 8.7.2 Lunan Pharmaceutical Business Overview
  40. 8.7.3 Lunan Pharmaceutical Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lunan Pharmaceutical Valacyclovir Oral Product Portfolio
  42. 8.7.5 Lunan Pharmaceutical Recent Developments
  43. 8.8 Zydus Pharmaceuticals
  44. 8.8.1 Zydus Pharmaceuticals Company Information
  45. 8.8.2 Zydus Pharmaceuticals Business Overview
  46. 8.8.3 Zydus Pharmaceuticals Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zydus Pharmaceuticals Valacyclovir Oral Product Portfolio
  48. 8.8.5 Zydus Pharmaceuticals Recent Developments
  49. 8.9 Wockhardt
  50. 8.9.1 Wockhardt Company Information
  51. 8.9.2 Wockhardt Business Overview
  52. 8.9.3 Wockhardt Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wockhardt Valacyclovir Oral Product Portfolio
  54. 8.9.5 Wockhardt Recent Developments
  55. 8.10 West-Ward Pharmaceuticals
  56. 8.10.1 West-Ward Pharmaceuticals Company Information
  57. 8.10.2 West-Ward Pharmaceuticals Business Overview
  58. 8.10.3 West-Ward Pharmaceuticals Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 West-Ward Pharmaceuticals Valacyclovir Oral Product Portfolio
  60. 8.10.5 West-Ward Pharmaceuticals Recent Developments
  61. 8.11 Time Cap Labs
  62. 8.11.1 Time Cap Labs Company Information
  63. 8.11.2 Time Cap Labs Business Overview
  64. 8.11.3 Time Cap Labs Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Time Cap Labs Valacyclovir Oral Product Portfolio
  66. 8.11.5 Time Cap Labs Recent Developments
  67. 8.12 Tasly
  68. 8.12.1 Tasly Company Information
  69. 8.12.2 Tasly Business Overview
  70. 8.12.3 Tasly Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tasly Valacyclovir Oral Product Portfolio
  72. 8.12.5 Tasly Recent Developments
  73. 8.13 Jubilant Pharma
  74. 8.13.1 Jubilant Pharma Company Information
  75. 8.13.2 Jubilant Pharma Business Overview
  76. 8.13.3 Jubilant Pharma Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jubilant Pharma Valacyclovir Oral Product Portfolio
  78. 8.13.5 Jubilant Pharma Recent Developments
  79. 8.14 Cipla
  80. 8.14.1 Cipla Company Information
  81. 8.14.2 Cipla Business Overview
  82. 8.14.3 Cipla Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cipla Valacyclovir Oral Product Portfolio
  84. 8.14.5 Cipla Recent Developments
  85. 8.15 Aurobindo Pharma
  86. 8.15.1 Aurobindo Pharma Company Information
  87. 8.15.2 Aurobindo Pharma Business Overview
  88. 8.15.3 Aurobindo Pharma Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Aurobindo Pharma Valacyclovir Oral Product Portfolio
  90. 8.15.5 Aurobindo Pharma Recent Developments
  91. 8.16 Apotex
  92. 8.16.1 Apotex Company Information
  93. 8.16.2 Apotex Business Overview
  94. 8.16.3 Apotex Valacyclovir Oral Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Apotex Valacyclovir Oral Product Portfolio
  96. 8.16.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valacyclovir Oral Value Chain Analysis
  2. 9.1.1 Valacyclovir Oral Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valacyclovir Oral Production Mode & Process
  6. 9.2 Valacyclovir Oral Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valacyclovir Oral Distributors
  9. 9.2.3 Valacyclovir Oral Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst